Real-time global intelligence

© 2026 OpenWatch. All rights reserved.

For informational and entertainment purposes only. Not investment advice.

Platform

Brief
Signals
Countries
Companies
Industries
Themes
Scenarios
Rankings

Tools

Globe
Analytics
Crises
Clusters
Supply Chain
Alliances
Screener
Watchlist
Portfolio

Developer

API Reference
Developer Keys
Webhooks
Status

Sources

View all sources →

1,000+ tracked sources

Signals updated every 15 minutes

Not investment advice. OpenWatch is provided for informational and entertainment purposes only. While we strive for accuracy, precision, and source attribution in all intelligence assessments, geopolitical analysis involves inherent uncertainty and our conclusions may be incomplete, delayed, or incorrect. Nothing on this platform constitutes financial, investment, legal, or professional advice of any kind. Forward-looking scenarios and probability estimates are analytical hypotheses — not independently validated forecasts. Any actions taken based on information found here are solely your responsibility. Always consult a qualified financial advisor before making investment decisions. Past signal patterns do not guarantee future outcomes.

Methodology
Privacy Policy
Terms of Use

openwatch.io

v·948999e

Signal Search

Search across all ingested intelligence signals. Supports websearch syntax: AND OR "exact phrase" -exclude

Keywords

Threat Layer

Military Cyber Economic Disaster Political Criminal Health Supply Chain

Signal Type

Any Crisis Update Resolution

Region

Country

Min. Severity

Any ≥ 3 ≥ 5 ≥ 7 ≥ 9

Date Range

Clear all filters

Sort by

Severity Newest

↓Export CSV (requires API key)

8 results for "Eli Lilly" · Update

Page 1 of 1

PoliticalUpdate20d ago

Novo Nordisk rejected Eli Lilly [5 sources]

6.5/10·GDELT Events Historical

Primary Source ↗Details →

PoliticalUpdate23d ago

Eli Lilly fought with Intelligence [10 sources]

6.5/10·GDELT Events Historical

Primary Source ↗Details →

PoliticalUpdate🇺🇸United States29d ago

Eli Lilly issued criticism in Bernardston [6 sources]

5.7/10·GDELT Events Historical

Primary Source ↗Details →

PoliticalUpdate🇺🇸United States30d ago

Eli Lilly issued criticism in Massachusetts [7 sources]

5.7/10·GDELT Events Historical

Primary Source ↗Details →

PoliticalUpdate🇺🇸United States30d ago

Eli Lilly issued criticism in Bernardston [6 sources]

5.7/10·GDELT Events Historical

Primary Source ↗Details →

Supply ChainUpdate🇺🇸United States17d ago

Novo Nordisk’s head start on GLP-1 pills forces investors to rethink Eli Lilly's dominance Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the opportunity for GLP-1 pills.

3.1/10·CNBC Business

Primary Source ↗Details →

EconomicUpdate21d ago

Eli Lilly announced a $2 billion increase to its full-year sales outlook and raised adjusted profit guidance, indicating strong business performance in the pharmaceutical sector.

2.5/10·CNBC World Economy

Primary Source ↗Details →

EconomicUpdate21d ago

Eli Lilly's weight loss pill launch has been closely watched after the successful start of Novo Nordisk's Wegovy pill. This represents standard competitive activity in the pharmaceutical market for obesity treatments.

2.5/10·CNBC World Economy

Primary Source ↗Details →